The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
Chief executive Jeff Greenslade expects OCR to stay on hold, with more ‘clarity’ about rate cuts later this year.
The market response was the opposite of the share slump that greeted Woolworths last week.
Shares in chemicals group down more than 40% on half-year result
Mark Aue will replace JB Rousselot in April as the regulated monopoly figures out its investment priorities.
Previous payouts were unsustainable, company says, as half year net profit falls 40%.
Fresh from reporting a record underlying profit, the company has its eyes set on expanding its footprint across the Tasman.
International competition is closing in on Australasia.
A spate of break-ins at New Zealand stores has sapped morale, affected staff retention, and ultimately affected sales in what was already a softer economy
Despite a large net loss due to revaluations, PFI says all-time low vacancies in our largest city will drive rents in its portfolio upwards.